PUBLISHER: The Business Research Company | PRODUCT CODE: 1670319
PUBLISHER: The Business Research Company | PRODUCT CODE: 1670319
A mobile c-arm comprises an image intensifier or flat-panel detector, an X-ray generator, and a workstation with controls and settings. It is commonly utilized in surgical settings, particularly in operating rooms, to provide real-time imaging during surgeries, as well as for angiography and fluoroscopy.
The primary product categories of mobile c-arms include mini c-arms, full-size c-arms, and others. Mini c-arms allow doctors to capture clear images and perform various therapies such as manipulations and injections. These systems find applications in orthopedics, trauma, cardiovascular procedures, pain management, urology, gastroenterology, neurology, among others. The diverse end users of mobile c-arms encompass hospitals, specialty clinics, and ambulatory surgical centers.
The mobile c-arms market research report is one of a series of new reports from The Business Research Company that provides mobile c-arms market statistics, including mobile c-arms industry global market size, regional shares, competitors with a mobile c-arms market share, detailed mobile c-arms market segments, market trends, and opportunities, and any further data you may need to thrive in the mobile c-arms industry. This mobile c-arms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The mobile C-arm market size has grown strongly in recent years. It will grow from $1.36 billion in 2024 to $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rise in minimally invasive procedures, aging population, diagnostic accuracy, hospital and clinic expansions, increasing surgical procedures
The mobile C-arm market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to portable and compact design, global healthcare infrastructure development, telemedicine and remote surgery, value-based healthcare, hybrid operating rooms. Major trends in the forecast period include integration with other imaging technologies, technological advancements, remote monitoring and diagnostics, customization and user-friendly interfaces, and AI-driven image enhancement.
The anticipated growth in the mobile c-arm market is expected to be driven by the rising incidences of chronic diseases. Chronic diseases, characterized by lasting three months or more, including conditions such as cardiovascular disease and cancer, can benefit from the use of mobile c-arm devices. These devices contribute to improved clinical outcomes, potentially reducing revision rates and overall healthcare spending. For example, as of January 2023, the National Library of Medicine reported a projected 99.5% increase in the number of individuals aged 50 and older with at least one chronic condition in the United States, reaching 142.66 million by 2050. Consequently, the growth of the mobile c-arm market is influenced by the escalating incidence of chronic diseases.
The rising number of surgical procedures is expected to drive the growth of the mobile C-arm market in the coming years. Surgical procedures involve medical interventions performed by surgeons to address conditions, alleviate symptoms, or enhance overall patient health. Mobile C-arms provide improved visualization, enhanced precision, increased safety, and support for various medical specialties. Their versatility and real-time imaging capabilities make them essential tools in modern operating rooms. For example, in June 2024, the International Society of Aesthetic Plastic Surgery reported a 3.4% increase in total surgical and non-surgical procedures in 2023, reaching 34.9 million. Notably, face and head procedures experienced significant growth, totaling over 6.5 million, with a 19.6% increase from the previous year. Leading procedures included eyelid surgeries, with over 1.7 million procedures and a 24% rise, rhinoplasty with 1.1 million procedures and a 21.6% increase, and lip enhancement/perioral procedures, which grew by 29% to 0.9 million. Thus, the increasing number of surgical procedures is propelling the growth of the mobile C-arm market.
Technological advancements emerge as a prominent trend gaining traction in the mobile C-arm market, with major companies in the sector adopting innovative technologies to maintain their market positions. For example, in May 2023, Koninklijke Philips N.V., a Netherlands-based health technology company, introduced the Philips image-guided therapy mobile C-arm system 1000, Zenition 10. This mobile arm system incorporates new flat panel detector technology from Philips, expanding access for more patients to routine surgical treatment and less invasive procedures. Philips Zenition 10 not only offers an affordable imaging solution but also provides the speed and efficiency necessary for handling high patient throughput. Its adaptability caters to the needs of various surgical specialties, including orthopedics and trauma, maximizing usage.
Major companies in the mobile C-arm market are focusing on developing innovative solutions, such as compact mobile C-arm imaging systems, to enhance their competitive advantage. These compact mobile C-arm imaging systems are highly valued in medical settings for the numerous benefits they provide to both patients and practitioners. For example, in February 2024, Royal Philips, a Netherlands-based technology company, launched the Zenition 90 Motorized mobile C-arm. This model is notable for its impressive speed and user-friendly design, allowing surgeons to control it easily from the table side. Its intuitive controls and time-saving features promote surgical flexibility and independence. The system is designed to deliver exceptional image quality, even in complex procedures, particularly for vascular applications. With automated workflows, a Touch Screen Module for image control, and advanced software solutions, the Zenition 90 Motorized significantly enhances clinical efficiency.
In July 2022, Canon Medical Systems, a Japan-based manufacturer of medical imaging equipment, acquired NXC Imaging for an undisclosed amount. This acquisition will enable Canon Medical Systems to expand its sales and service outreach in the Upper Midwest region. The company aims to establish a strong sales and service organization in this area, offering innovative solutions and customized business models tailored to meet the specific needs of each client. NXC Imaging is a US-based manufacturer specializing in mobile C-arms.
Major companies operating in the mobile C-arm market include Siemens Healthineers AG, Fujifilm Middle East FZE, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Shimadzu Corporation, Hologic Inc., Heal Force, Hitachi Medical Systems, Canon Medical Systems Corporation, Ziehm Imaging GmbH, Avante Health Solutions, DMS Group, OrthoScan Inc., Allengers Medical Systems Limited, Eurocolumbus srl, Eurocolumbus s.r.l., Summit Industries, Turner Imaging System, Intermedical S.r.l., Perlong Medical Equipment Co. Ltd., Gemss Medical Systems, Alpha Medical Equipment, ARI Medical Equipment Co. Ltd., SternMed GmBH, Villa Sistemi Medicali S.p.A., MS Westfalia GmbH, Nanjing Perlove Medical Equipment Co. Ltd., Hi-Tech Medi Systems, GMM Group, Vision Medicaid Equipment Private Limited
North America was the largest region in the mobile C-arm market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile c-arm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the mobile c-arm market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The mobile c-arm market consists of sales of compact c-arms and super c-arms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Mobile C-arm Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on mobile c-arm market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for mobile c-arm ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mobile c-arm market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.